A stearoyl-CoA desaturase inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

GSK1940029

Item No. 36704

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide
CAS Number
1150701-66-8
Molecular Formula
C18H16Cl2N4O2
Formula Weight
391.3
Purity
≥98%
Formulation
A solid
Solubility(Learn about Variance in Solubility)
DMSO: Soluble
λmax
268 nm
SMILES
CC1=C(C(NC2=CC=C(CO)C=C2)=O)N=NN1CC3=CC(Cl)=C(Cl)C=C3
InChi Code
InChI=1S/C18H16Cl2N4O2/c1-11-17(18(26)21-14-5-2-12(10-25)3-6-14)22-23-24(11)9-13-4-7-15(19)16(20)8-13/h2-8,25H,9-10H2,1H3,(H,21,26)
InChi Key
QQRGSFYTPBYCFD-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 mg

    $29

    Add

    5 mg

    $85

    Add

    10 mg

    $156

    Add

    25 mg

    $281

    Add
    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    GSK1940029 is a stearoyl-CoA desaturase (SCD) inhibitor.1 It increases palmitate-induced phosphorylation of p70 ribosomal S6 kinase 1 (p70S6K1) and lactate dehydrogenase (LDH) release from AML12 hepatocytes when used at a concentration of 20 µM.2 GSK1940029 (10 µM) also increases palmitate-induced increases in extracellular and intracellular triglyceride levels in AML12 hepatocytes, an effect that can be reversed by the mammalian target of rapamycin (mTOR) inhibitor torin 1 (Item No. 10997).

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Bouillot, A.M.J., Laroze, A., and Trottet, L. 1,2,3-triazole derivatives for use as stearoyl-coa desaturase inhibitors. (2009).

    2. Wang, J., Chen, Y., Song, Q., et al. mTORC1-IRE1α pathway activation contributes to palmitate-elicited triglyceride secretion and cell death in hepatocytes. Exp. Biol. Med. (Maywood) 245(14), 1268-1279 (2020).